Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

Early humoral immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus neutralization at mucosal sites. Given the essential roles of IgM and IgA in the control and elimination of SARS-CoV-2 infection,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingjing, Zhang, Han, Sun, Litao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890389/
https://www.ncbi.nlm.nih.gov/pubmed/35220888
http://dx.doi.org/10.1080/19420862.2022.2031483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890389/
https://www.ncbi.nlm.nih.gov/pubmed/35220888
http://dx.doi.org/10.1080/19420862.2022.2031483

Ejemplares similares